TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
IMVT

Immunovant Inc

Healthcare · Biotechnology

34.00$ -1.6% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement IMVT
Line item 2018 2018 2019 2020 2021 2022 2023 2024 2025 2026
– – – – – – – – – –
– – – – +4,652.4% +23.4% +7.5% -82.6% +63.2% +8.5%
– – – – – – – – – –
– – – +86.2% +43.1% +48.4% +57.4% +32.9% +69.5% +26.5%
– – – +574.3% +117.7% +37.2% -11.4% +19.3% +34.8% -1.3%
– – – +13,257,011.1% +81.2% +44.3% +33.5% +29.7% +62.2% +21.6%
– – – – – – – – – –
– – – – -100.0% – +1,805.6% +299.7% – –
– – – – – – – – – –
– – – +410.5% -469.1% – – +6,200.0% +57.1% -75.9%
– – – – – – – – – –
– – – – – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?